RecruitingNCT06906432

Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage

Multimodal Omics and Imaging Study on the Mechanisms of Brain-heart Injury in Patients With Intracranial Hemorrhage


Sponsor

Beijing Tiantan Hospital

Enrollment

1,000 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Intracranial hemorrhage is a condition characterized by high mortality rates and suboptimal functional outcomes. It precipitates both direct brain injury and subsequent secondary injuries, including delayed cerebral ischemia, brain edema, and hydrocephalus. Complications such as cardiac injury may also arise, categorizing them within the cerebrocardiac syndrome (CCS). The clinical spectrum of CCS encompasses acute myocardial injury, acute coronary syndrome, left ventricular systolic and diastolic dysfunction, cardiac arrhythmias, and sudden cardiac death, all of which are associated with increased mortality and deterioration in patient status. The precise pathophysiological mechanisms underlying both cerebral and cardiac injuries remain enigmatic, and the implications for diagnosis and therapeutic strategies are yet to be fully explored. In this study, we propose to enroll patients with intracranial hemorrhage who will undergo conventional treatment and comprehensive multidisciplinary evaluations. Our observational research is grounded in a multimodal omics and imaging approach, aimed at investigating both local and systemic injuries subsequent to intracranial hemorrhage. This comprehensive strategy is intended to facilitate precise diagnosis, risk stratification, and clinical decision-making, while also shedding light on the pathophysiological mechanisms involved. The primary objectives of this research are to address the following key questions: * \[Question 1\] What are the pathophysiological mechanisms underlying cardiac injury in patients with intracranial hemorrhage? * \[Question 2\] What are the pathophysiological mechanisms responsible for early and delayed brain injuries following intracranial hemorrhage?\"


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how bleeding in or around the brain (intracranial hemorrhage) affects the heart, with the goal of better understanding the connection between brain injury and heart damage — sometimes called "brain-heart injury." **You may be eligible if...** - You are 18 or older - You have had an acute (sudden) bleed in or around the brain confirmed by imaging within the past 48 hours - You or a legally authorized representative can give consent **You may NOT be eligible if...** - You refuse to participate - You have a significant pre-existing heart condition (such as a prior heart attack, heart failure, or irregular heartbeat) that is not stable and well-controlled - You have had heart surgery, a stent, or another heart procedure within the past 6 months - You have an active brain tumor or had a stroke within the past 3 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMulti-disciplinary assessment

Multi-disciplinary assessment including blood tests, CSF test, electrocardiograms, ultrasound, imaging, etc


Locations(1)

Beijing Tiantan Hospital Affiliated to Capital Medical University

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06906432


Related Trials